Biotech

All Articles

Lilly- backed effective weight loss biotech documents IPO

.After raising $170 million back in February, metabolic disease-focused BioAge Labs has actually fil...

Aelis' cannabis usage medicine fails period 2b, driving Indivior to review $100M option

.Aelis Farma's chances of securing a quick, beneficial selection on a $one hundred million possibili...

ProKidney halts phase 3 test certainly not required for tissue therapy approval

.ProKidney has quit one of a set of stage 3 tests for its own tissue therapy for kidney condition af...

Vaxcyte rises on 'magnificent' 31-valent PCV succeed versus Pfizer

.Vaxcyte introduced what analysts referred to as "spectacular" period 1/2 records for its 31-valent ...

Recursion's human brain health condition trial shows little documentation of efficacy

.Recursion has actually discovered with a very early test of its tech-enabled approach to medicine r...

Acepodia, Pfizer click on together for chemistry-based cell treatment

.Phone it a scenario of really good chemistry: Acepodia, a biotech based on Nobel Prize-winning scie...

Praxis epilepsy medicine lowers confiscations in phase 2 trial

.Praxis Precision Medicines has actually scored another midphase win in epilepsy this year, with its...

Three officers resign as Dyne posts blended records for DMD applicant

.After running away a scientific hold numerous years back, Dyne Rehab has actually exposed new stage...

Arrowhead fires off phase 3 data in rare metabolic disease in advance of market encounter Ionis

.Arrowhead Pharmaceuticals has actually shown its hand before a prospective face-off along with Ioni...

Pfizer, Valneva reveal lyme ailment chance reliable for 2nd booster

.Pfizer and Valneva may have concerning 2 more years to stand by prior to they produce the initial p...